Effect of greater occipital nerve block in treatment of headache

Evaluation of the effect of greater occipital nerve block in the treatment of medication overuse headache

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150906023922N2

Enrollment

Registered

2020-07-29

Start date

2019-10-17

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication overuse headache. Other headache syndromes

Interventions

Intervention 1: Intervention group: The greater occipital nerve will be blocked bilaterally using 1 ml of 2% lidocaine and 1 ml of triamcinolone 40 mg / ml. Patients in the intervention group will und

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (aged >18 years) Having confirmed diagnosis of medication overuse headache (MOH) Previous diagnosis of a primary headache

Exclusion criteria

Exclusion criteria: Psychiatric disorders (e.g. severe depression or schizophrenia) Physical disorders (e.g. malignancy, concomitant heart disease) Pregnant or lactating

Design outcomes

Primary

Measure	Time frame
Headache severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Visual analogue scale.;Headache frequency. Timepoint: At baseline and after 12 weeks. Method of measurement: Record.;Headache duration. Timepoint: At baseline and after 12 weeks. Method of measurement: Record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariborz Khorvash

Esfahan University of Medical Sciences

fkhorvash@med.mui.ac.ir+98 31 3650 3584

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026